CUSIP: 89620X506
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,448,100
-
Share change
-
+242,563
-
Total reported value
-
$44,811,000
-
Price per share
-
$13.03
-
Number of holders
-
29
-
Value change
-
+$1,231,989
-
Number of buys
-
16
-
Number of sells
-
12
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2015
As of 30 Sep 2015,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,448,100 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, Private Capital Advisors, Inc., FRANKLIN RESOURCES INC, EverPoint Asset Management, LLC, venBio Select Advisor LLC, Opaleye Management Inc., Point72 Asset Management, L.P., DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.